MAM
AGN

Melqart Asset Management’s Allergan plc AGN Stock Holding History

Melqart Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-870,500
Closed -$154M – 57
2020
Q1 		$154M Buy
870,500
+166,500
+24% +$31.4M 15.13% 1
2019
Q4 		$135M Buy
704,000
+95,300
+16% +$17.2M 11.28% 1
2019
Q3 		$102M Buy
608,700
+330,700
+119% +$53.9M 9.3% 3
2019
Q2 		$46.5M Buy
+278,000
New +$38.5M 3.2% 12

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Melqart Asset Management's AGN Position: Q2 2020 in Review

Melqart Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 870,500 shares — an estimated $154M sold.

Melqart Asset Management first reported a position in AGN in Q2 2019 and held it in 4 quarters. The position peaked at $154M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Melqart Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Melqart Asset Management sold 870,500 Allergan plc shares in Q2 2020, an estimated $154M.
  • Melqart Asset Management first reported a position in Allergan plc in Q2 2019 and held it in 4 quarters.
  • Melqart Asset Management's Allergan plc position peaked at $154M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Melqart Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.